Developing novel, effective therapeutics for neurodegenerative disorders.

  • Neuro-Bio is a biotechnology company taking a new approach to neurodegenerative disorders including Alzheimer’s, Parkinson’s and Motor Neuron Diseases
  • Founded on 40 years of neuroscience research, Neuro-Bio was the first to identify a novel mechanism driving the cycle of brain cell death in selectively vulnerable cell groups
  • Its approach has shown the production of beta-amyloid and tau to be secondary phenomena in neurodegeneration
  • Neuro-Bio is developing novel drug candidates that could be the first to halt the neurodegenerative process
  • Also exploring the use of its approach in biomarkers and pre-symptomatic diagnosis of neurodegenerative disorders
  • The same mechanism also has potential oncology applications in metastatic cancers